Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

Clinical trial NCT02533570 · TERMINATED

Trial details

NCT number: NCT02533570
Sponsor: Seagen Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2015-07-01
Primary completion: 2017-06-05
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.